mdpk67b
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 21, 2017 (NCT04839120)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Kallikrein 1INHIBITOR
Kallikrein 1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05580107 | Phase 1 | Aug 9, 2021 | Med Discovery SA, Soladis |
| NCT04839120 | Phase 1 | Feb 21, 2017 | Med Discovery SA |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Med Discovery SA | For profit | 2 | 2 | 1 | 2017 |
| Soladis | For profit | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1